Brief: IGM Biosciences Announces Q3 2021 Financial Results And Provides Corporate Update
04/11/2021 13:38
Nov 4 (Reuters) - IGM Biosciences Inc IGMS.O :
* IGM BIOSCIENCES ANNOUNCES THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE $1.32
* REITERATES PREVIOUSLY ISSUED FINANCIAL GUIDANCE EXPECTING
FY2021
GAAP OPERATING EXPENSES BETWEEN $175 MILLION - $185 MILLION
* Q3 EARNINGS PER SHARE VIEW $-1.37 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7GX6z8
Further company coverage: IGMS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary